The Downtown Traverse City Association seeks non-profit recognition from the Traverse City City Commission to secure a state ...
After promising results from separate Phase 2 and 3 trials, Cidara Therapeutics has submitted a new drug application to the US Food and Drug Administration (FDA) for the compound rezafungin, for which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results